Back
GDS Holdings Vs. Janux Therapeutics Industry Stock Comparison
Buy
59
GDS
GDS Holdings
Last Price:
20.72
Seasonality Move:
0.1%
Sell
34
JANX
Janux Therapeutics
Last Price:
64.49
Seasonality Move:
133.13%
Buy
59
GDS Holdings (GDS)
is a Buy
Is GDS Holdings a Buy, Sell or Hold?
- The current GDS Holdings [GDS] share price is $20.84. The Score for GDS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- GDS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $63.45. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDS Stock Price Chart
What is GDS Holdings's stock price today?
-
The GDS Holdings share price today is $20.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDS is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $63.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight buying pressure.
GDS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 51.61 | Buy |
| Chaikin Money Flow: | 266117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.07 - 22.59) | Buy |
| Bollinger Bands (100): | (13.95 - 22.19) | Buy |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.37 | Buy |
| Relative Strength Index (14 RSI): | 62.61 | Buy |
| Chaikin Money Flow: | 83260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.42 - 60.66) | Buy |
| Bollinger Bands (100): | (41.37 - 54.41) | Buy |
GDS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.56 | Buy |
| 20-day SMA: | 20.29 | Buy |
| 50-day SMA: | 21.21 | Sell |
| 200-day SMA: | 13.21 | Buy |
| 8-day EMA: | 20.58 | Buy |
| 20-day EMA: | 20.53 | Buy |
| 50-day EMA: | 20.18 | Buy |
| 200-day EMA: | 15.48 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.7 | Buy |
| 20-day SMA: | 53.44 | Buy |
| 50-day SMA: | 51.89 | Buy |
| 200-day SMA: | 46.41 | Buy |
| 8-day EMA: | 60.46 | Buy |
| 20-day EMA: | 56.17 | Buy |
| 50-day EMA: | 52.56 | Buy |
| 200-day EMA: | 43.06 | Buy |
GDS Holdings Earnings Growth & GDS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $0.32 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.97 per share.
GDS Holdings Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||